BCL9 and neoplasm: Increased mRNA levels of Gli1 and Ptch1 were seen in hsBCL9CT-24 or Bcl9-shRNA treated CT26 tumor cells (Fig. 6l, m, Supplementary Fig. 6e, f), suggesting that BCL9 suppression activates CD155 expression via sonic hedgehog signaling.